Melinda Dessieux
Family · Shawnee Mission, KSNPI 1386276921
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 207 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 23.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,361 and has fallen 97.4% since, to $35 in 2024.
Across 207 payments — averaging $12.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$612
- Teva Pharmaceuticals USA, Inc.$314
- Sanofi$211
- Biohaven Pharmaceuticals, Inc.$191
- Johnson & Johnson$185
- Biohaven Pharmaceutical Holding Company Ltd.$133
- plus $942 from 24 others
What the payments were for
- Food & beverage$2,589100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 58 | $612 |
| Teva Pharmaceuticals USA, Inc. | 47 | $314 |
| Sanofi | 10 | $211 |
| Biohaven Pharmaceuticals, Inc. | 15 | $191 |
| Johnson & Johnson | 11 | $185 |
| Biohaven Pharmaceutical Holding Company Ltd. | 13 | $133 |
| UCB, Inc. | 7 | $109 |
| Amgen | 5 | $92 |
| Jazz Pharmaceuticals Inc. | 3 | $80 |
| Bristol Myers Squibb | 3 | $68 |
| Banner Life Sciences, LLC | 4 | $65 |
| EMD Serono, Inc. | 3 | $56 |
| Boston Scientific | 2 | $49 |
| AstraZeneca(2 entities) | 3 | $48 |
| SK Life Science, Inc. | 2 | $44 |
| Amneal Pharmaceuticals LLC | 2 | $33 |
| Eisai Inc. | 2 | $33 |
| Avion Pharmaceuticals | 2 | $33 |
| Kyowa Kirin, Inc. | 2 | $30 |
| Neurelis, Inc. | 2 | $29 |
| Novartis | 2 | $26 |
| Acorda Therapeutics, Inc | 1 | $22 |
| Lundbeck LLC | 1 | $21 |
| Genentech USA, Inc. | 1 | $21 |
| Actelion Pharmaceuticals US, Inc. | 1 | $20 |
| Medtronic | 1 | $15 |
| Pfizer | 1 | $14 |
| Arbor Pharmaceuticals, Inc. | 1 | $13 |
| Adamas Pharmaceuticals, Inc. | 1 | $12 |
| Neurocrine Biosciences, Inc. | 1 | $11 |
How this compares
$2,589 in reported general payments places this provider in the 85th percentile of 1,579 family providers in Kansas.
Other family in Shawnee Mission
- Zohra HussainiKansas City$329K
- Jennifer ChesterOverland Park$327K
- Amanda CaldwellLeawood$203K
- Kayla del RioWichita$147K
- Kelli RiceWichita$114K
- Tatum TolandTopeka$108K
- Mary GonzalesWichita$87K
- Erin FeitzOverland Park$36K
- Adam CaseKansas City$34K
- Jaimie HeldstabWestwood$30K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.